On April 4, 2024, Floreo, a leading behavioral therapy virtual reality (VR) company, announced the acquisition of Autism Eyes, an autism diagnostics and assessment company created by Cleveland Clinic Innovations. The addition also coincides with Cleveland Clinic's strategic investment into Floreo. Wilson Sonsini Goodrich & Rosati advised Floreo on the transaction.

Floreo's acquisition of Autism Eyes represents an important expansion of Floreo’s business and clinical model into the virtual diagnostics and assessment. The integration of Floreo’s VR platform combined with eye-tracking capabilities of Autism Eyes is a potentially game-changing innovation for autism diagnosis and a practical use case for VR technology.

The Wilson Sonsini team that advised Floreo on the transaction includes Seth Helfgott, Dave Strong, Ian Edvalson, Avi Emanuel, Jon Hatcher, Nate Lees, Anthony Yanez, Jun Hyung Lee, and Lori Walker.

For more information, please see Floreo's news release.